Abstract
Opioid maintenance treatment with methadone or buprenorphine is an established first-line treatment for opioid dependence. In addition to the novel weekly and monthly subcutaneously injectable buprenorphine depot CAM 2038 (Buvidal (R)), which is already available in Germany, two other long-acting buprenorphine formulations may be introduced in the near future: the monthly depot formulation RBP-6000 (Sublocade (TM)) and a 6-month buprenorphine depot implant (Probuphine (TM)). Basic pharmacological and clinical data of these three medications are given and possible clinical applications are discussed.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Medizin |
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| ISSN: | 0028-2804 |
| Sprache: | Deutsch |
| Dokumenten ID: | 79253 |
| Datum der Veröffentlichung auf Open Access LMU: | 15. Dez. 2021 14:47 |
| Letzte Änderungen: | 15. Dez. 2021 14:47 |
- Dokument bearbeiten
